A Review on Rubella Vaccine: Iran (1975-2019) [PDF]
Archives of Razi Institute, 2021 The first Attenuated rubella vaccine was developed by Parkman and Meyer in 1966. Ten years later in the 1975s, the rubella vaccine was developed in Razi Vaccine and serum research institute) RVSRI).
A Shafayi, A Mohammadi
doaj +2 more sources
Post Vaccine Rubella During a Measles Outbreak: Clinical Case
Acta Médica Portuguesa, 2021 Rubella is a vaccine preventable infection, and congenital rubella the most feared complication of this disease. Although young adult women are at greatest risk of post-vaccine rubella, this is also the group who potentially benefits the most from ...
Luísa Graça +3 more
doaj +1 more source
A Case of Rubella Caused by Rubella Vaccination
Vaccines, 2021 We present an extremely rare case of rubella that developed after rubella vaccine administration. A 54-year-old man complained of back and neck pain for some days.
Momoka Kamada, Tsuneaki Kenzaka
doaj +1 more source
Past as Prologue—Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination
Emerging Infectious Diseases, 2022 The rapid rollout of vaccines against COVID-19 as a key mitigation strategy to end the global pandemic might be informed by lessons learned from rubella vaccine implementation in response to the global rubella epidemic of 1963–1965.
Meredith G. Dixon +3 more
doaj +1 more source
Efficacy of Rubella Vaccination after Co-Inoculation with Rhogam
Viruses, 2023 Congenital rubella syndrome is a constellation of birth defects that can have devastating consequences, impacting approximately 100,000 births worldwide each year. The incidence is much lower in countries that routinely vaccinate their population. In the
Joshua S. Brunton +5 more
doaj +1 more source
Вопросы вирусологии, 2021 Introduction. Rubella virus has pronounced teratogenic properties that can cause generalized and persistent intrauterine infection of the fetus. As a result, the control of the loss of teratogenicity inherent in «wild-type» virus strains is a necessary ...
I. N. Lavrentjeva +4 more
doaj +1 more source
Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine. [PDF]
PLoS ONE, 2018 Measles outbreaks have occurred in some countries despite supplementary immunization activities (SIA) using measles-containing vaccine with high vaccination coverage. We conducted a cross-sectional seroprevalence survey to estimate population immunity in
Masahiko Hachiya +15 more
doaj +1 more source
Vaccine-associated Rubella – a report of two cases and a review of the literature
Human Vaccines & Immunotherapeutics, 2021 We report the clinical characteristics of two adult patients, presenting with a typical erythematous rash consistent with rubella disease after MMR vaccination. Both patients had an uncomplicated clinical course and recovered uneventfully.
Sean Wei Xiang Ong +9 more
doaj +1 more source
Balancing evidence and uncertainty when considering rubella vaccine introduction. [PDF]
PLoS ONE, 2013 BACKGROUND:Despite a safe and effective vaccine, rubella vaccination programs with inadequate coverage can raise the average age of rubella infection; thereby increasing rubella cases among pregnant women and the resulting congenital rubella syndrome ...
Justin Lessler, C Jessica E Metcalf
doaj +1 more source
Changes in the Epidemiology of Rubella: The Influence of Vaccine-Introducing Methods and COVID-19
Vaccines, 2023 Rubella is an infectious disease caused by the rubella virus. Congenital rubella syndrome is a risk for all newborns if pregnant women are infected with rubella, raising an important public health issue.
Naruhito Otani +6 more
doaj +1 more source